Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Dapsone (topical) vs Efinaconazole: they're closely matched on evidence (6 vs 6.5/10); the best pick depends on your goals. Take the 2-minute quiz for a pick tailored to your goals.
Dapsone (topical) and Efinaconazole are closely matched across evidence, studies, and safety.
Verdict
Too few graded studies
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (1)
Outcomes where both Dapsone (topical) and Efinaconazole have evidence — compare verdict strength side-by-side.
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Morning, Evening
Dapsone 5% gel
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Evening
Efinaconazole 10% topical solution
long-term
short-term
immediate
long-term
long-term
long-term
long-term
long-term
Efficacy and safety of dapsone gel for acne: a systematic review and meta-analysis
Ann Palliat Med (2022) · Meta-Analysis · n=11424
7 trials, 11,424 participants, searched across seven databases including four Chinese-language ones.
Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris
J Am Acad Dermatol (2007) · RCT · n=3010
Two identically designed 12-week randomised double-blind vehicle-controlled studies, 3,010 patients aged 12 and over, twice-daily monotherapy.
The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable
J Drugs Dermatol (2012) · RCT · n=2898
POST-HOC pooled analysis of the two identical phase 3 vehicle-controlled trials (DAP0203 and DAP0204), 2,898 patients, US and Canada, 2002-2003. Sex was not randomised.
Topical and device-based treatments for fungal infections of the toenails
Cochrane Database Syst Rev (2020) · Meta-Analysis · n=12501
56 studies, 12,501 participants across all topical and device-based treatments for toenail onychomycosis.
Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies
J Am Acad Dermatol (2013) · RCT · n=1655
Two identical multicentre randomised double-blind vehicle-controlled studies, 870 and 785 patients, randomised 3:1, once daily for 48 weeks with 4-week follow-up.
Efinaconazole 10% solution in the treatment of onychomycosis of the toenails
J Am Podiatr Med Assoc (2014) · Review · n=1655
Pooled report of the two pivotal trials across the United States, Canada and Japan, 1,655 patients.
Both Dapsone (topical) and Efinaconazole are closely matched — the best choice depends on your specific health goals.
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.